Immunome IMNM
NASDAQ IMNM
$20.94 +0.06 (+0.26%)
As of: Oct 2, 2026 · 11:25 AM EDT

Immunome (IMNM) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Immunome (IMNM) recorded Depreciation & Amortization (CF) of $957,000 in Q2 2026, up 50.2% from $637,000 a year earlier and up 58.7% from the prior quarter.

Analysis

Immunome (IMNM) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a TTM basis, Immunome's Depreciation & Amortization (CF) came in at $2.81 million as of Jun 30, 2026, up 31.3% year-over-year; for FY2025, it was $2.5 million, up 56.3% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for three straight years, with a five-year compound annual growth rate of 25.6% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $1.6 million in FY2024 (+220.0%), $500,000 in FY2023 (+18.5%), $422,000 in FY2022 (-47.3%) and $800,000 in FY2021 (unchanged).
  • The Q2 2026 figure is the highest quarterly Depreciation & Amortization (CF) in data going back to Q4 2019.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in seven of the last eight quarters, with growth averaging 106.7%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 443.6% in Q2 2024, against a decline of 64.0% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $603,000 (Q1 2026), $663,000 (Q4 2025) and $589,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Immunome 2.44 Bn 410.39 Mn - 957,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 957,000.00
Mar 31, 2026 603,000.00
Dec 31, 2025 663,000.00
Sep 30, 2025 589,000.00
Jun 30, 2025 637,000.00
Mar 31, 2025 611,000.00
Dec 31, 2024 483,000.00
Sep 30, 2024 411,000.00
Jun 30, 2024 549,000.00
Mar 31, 2024 157,000.00
Dec 31, 2023 194,000.00
Sep 30, 2023 111,000.00
Jun 30, 2023 101,000.00
Mar 31, 2023 94,000.00
Dec 31, 2022 95,000.00
Sep 30, 2022 103,000.00
Jun 30, 2022 113,000.00
Mar 31, 2022 111,000.00
Dec 31, 2021 163,000.00
Sep 30, 2021 286,000.00
API Access

Immunome Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IMNM&period=max&api_key=YOUR_API_KEY